Novel Coronavirus Pneumonia (COVID-19)
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with severe and critical COVID-19 diagnosed in accordance with the Novel Coronavirus infected Pneumonia Diagnosis and Treatment Plan (Trial Version 6); 2. Aged >=18 years, both men and women; 3. Agree to participate in this test and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who cannot receive Chinese medicine treatment; 2. Patients with allergies to certain traditional Chinese medicine decoctions or traditional Chinese medicine injections; 3. Cases where complete diagnosis and treatment information cannot be obtained; 4. Any other chronic respiratory diseases, respiratory bacterial infections such as purulent tonsillitis, acute tracheobronchitis, sinusitis, otitis media, and other respiratory diseases affecting clinical trial evaluation; 5. Accompanied by basic diseases such as severe primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformation, congenital heart disease, and abnormal lung development; 6. Expected survival time is less than 1 week. Note: Anyone who meets any of the above exclusion criteria cannot be included in this test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the ratio of patients transforming from severe/critical to light;fatality rate;Non-invasive/invasive mechanical ventilation time; | — |
Secondary
| Measure | Time frame |
|---|---|
| c reactive protein;Creatine Kinase Isoenzyme;Acute physiological and chronic health scores;Nucleic acid detection of novel coronavirus;troponin;arterial blood gas analysis;blood routine examination;ICU hospitalization days + total days in hospital;myohemoglobin;Modified sequential organ failure estimation score;D - dimer;erythrocyte sedimentation rate;procalcitonin;CT Scan-Chest; | — |
Countries
China
Contacts
Hospital of Chengdu University of Traditional Chinese Medicine